SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gufic Biosciences informs about outcome of board meeting

14 Feb 2020 Evaluate

Gufic Biosciences has informed that the Board of Directors of the Company at its meeting held on Thursday, February 13, 2020 commenced at 07.30 pm and concluded at 10:45 pm. The meeting transacted the following businesses: Considered and approved the Un-audited Financial Results of the Company for the quarter and Nine months ended December 31, 2019, which are enclosed herewith along with the Limited Review Report received from the Statutory Auditor of the Company on the said Un-Audited Financial Results; Approved the updated Code of Conduct for Prevention of Insider Trading in line with the amended provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. The said Code of Conduct is updated on the website of the Company and is available for the stakeholders of the Company at www.gufic.com; Appointed Gajanan D. Athavale, Practicing Company Secretaries as the Secretarial Auditor of the Company to conduct Secretarial Audit of the Company for the Financial year 2019-20. The details required under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015 read with SEBI circular no CIR/ CFD/ CMD/ 4/2015, dated September 09, 2015 is enclosed as Annexure 1; and in terms of Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the company enclosed details of authorized persons for purpose of determining materiality of events or information and for the purpose of making disclosure to stock exchange: Also enclosed the financial highlights for the quarter and nine months ended December 31, 2019.

The above information is a part of company’s filings submitted to BSE.


Gufic Biosciences Share Price

301.30 -1.35 (-0.45%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×